Table 2.
Variable | aOR (95% CI) | P b |
---|---|---|
IPLC diagnosis (%) | ||
No | 1.00 (Referent) | |
Yesc | 5.12 (3.38 to 7.98) | <.001 |
BMI (kg/m2) | 0.97 (0.95 to 1.00) | .07 |
Age at baseline, y | 1.03 (1.01 to 1.05) | .003 |
Pack-years | 0.97 (0.96 to 0.98) | <.001 |
Family history of lung cancer, % | ||
No | 1.00 (Referent) | |
Yes | 1.77 (1.08 to 2.95) | .03 |
Race (%) | ||
White | 1.00 (Referent) | |
African American | 0.60 (0.39 to 0.92) | .02 |
Japanese American | 0.89 (0.60 to 1.33) | .58 |
Latino | 0.57 (0.35 to 0.92) | .02 |
Native Hawaiian | 0.51 (0.31 to 0.84) | .009 |
Other | 1.18 (0.52 to 2.75) | .70 |
Based on n = 986 patients who were 1) current smokers at baseline, 2) had 10-year follow-up information, and 3) were diagnosed with IPLC between 1993 and 2017. aOR = adjusted odds ratio; CI = confidence interval; BMI = body mass index; IPLC = initial primary lung cancer; MEC = Multiethnic Cohort.
P value was calculated using the 2-sided Wald test.
IPLC diagnosis between baseline (1993-1996) and 10-year follow-up (2003-2008).